The comments on our paper (Morabia et al, 2000) in the editorial by Vieth and Carter (Vieth & Carter, 2001 ) re¯ect an unfortunately common misinterpretation of epidemiologic data.
The aim of our paper was to explore differences in vitamin D intake between current and never smokers that might contribute to the increased risk of bone mass loss among smokers. It was not to assess adequacy of vitamin D intake in the population. If that was our objective we would have proceeded differently. Vieth and Carter (2001) write that the 0.47 mgaday mean difference ( 2.39 ± 1.92) in vitamin D intake between heavy smokers and never smokers that we reported has no practical implication even if it is statistically signi®cant. We disagree. The difference of 0.47 mgaday indicates that, on average, current heavy smokers have lower intakes of vitamin D than never smokers. Such a small difference does not reveal the magnitude of the vitamin D de®cit prevalence in the population. There are known techniques for utilizing the population mean requirement to derive the de®cit prevalence for subgroups at risk (Beaton, 1971; Anderson et al, 1982) . We illustrate this approach in Table 1 , where we have applied the methodology proposed by Guthrie (Guthrie, 1989) .
To estimate the probability that individuals within subgroups of our population will have insuf®cient vitamin D intakes, we have calculated the cumulative percentage of subjects expected to have an intake less than the mean requirement. As recommended by Guthrie, we de®ned the mean requirement of vitamin D as being 100a130 below the RDA of 5.0 mgaday (Committee on Dietary Allowances 1989), that is, 100 Â 5.0a130 3.85 mga day, and we also derived the standard deviation of 0.58 assuming a coef®cient of variation of 15%. Table 1 shows the probabilities and the expected prevalences of de®ciency for 12 separate categories of vitamin D intake. For example, the cumulative expected prevalences of de®cit for the intake category with a mid-point of 2.5 mgaday are 59.6%, 64.9% and 71.3%, respectively, for never smokers and current smokers of 1 ± 19 and 20 cigarettesaday. Thus, even a small mean difference of intake between subgroups (0.47 mgaday) can hide substantial differences in expected prevalence of vitamin D de®cit. The overall cumulative probabilities vary between 78% and f Probability cumulative multiplication of (probability of de®ciency) Â (% in interval).
86% but it is important to note that they depend heavily on the choice of the RDA value. Our estimates also need to be interpreted with caution since food frequency questionnaires may not capture all of the vitamin D intake. This is precisely why we focused on differential intakes according to smoking status. The goal of our study (Morabia et al, 2000) has been inaccurately summarized by Vieth and Carter (Vieth & Carter, 2001) . We have reported that salmon, 45% fat cheese, margarine and eggs are the most important sources of vitamin D in the Geneva population. These food items are eaten more often by never smokers than by smokers. In addition, among people who consume these products, never smokers have a higher intake of vitamin D from these sources than smokers. Thus, we concluded that:`If con®rmed, our ®ndings have important clinical and public health signi®cance since they can lead to the straightforward recommendation to smokers to increase their intake of food rich in calcium and vitamin D, such as, for example, eating at least one low-fat yogurt per day and having regular servings of ®sh'. This message can easily be translated into an understandable mass information campaign.
